1. Loera-Valencia, R, Piras, A, Ismail, M A M, Winblad, B, Nilsson, P. . Targeting Alzheimer's disease with gene and cell therapies. In Journal of internal medicine, 284, 2-36. doi:10.1111/joim.12759. https://pubmed.ncbi.nlm.nih.gov/29582495/
2. Huoshen, Wuda, Zhu, Hanfang, Xiong, Junkai, Sun, Chen, Li, Chunhui. 2024. Identification of Potential Biomarkers and Therapeutic Targets for Periodontitis. In International dental journal, 75, 1370-1383. doi:10.1016/j.identj.2024.10.006. https://pubmed.ncbi.nlm.nih.gov/39532570/
3. Yazdanpanah, Mahboobeh, Jalilian, Nazanin, Abdollah Zadeh, Rasoul, Sahraian, Mohammad Ali, Noori-Daloii, Mohammad Reza. 2021. Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population. In The International journal of neuroscience, 132, 1037-1042. doi:10.1080/00207454.2020.1860964. https://pubmed.ncbi.nlm.nih.gov/33491520/
4. Deshmukh, Harshal A, Maiti, Amit K, Kim-Howard, Xana R, Anaya, Juan-Manuel, Nath, Swapan K. 2011. Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction. In The Journal of rheumatology, 38, 1866-70. doi:10.3899/jrheum.110199. https://pubmed.ncbi.nlm.nih.gov/21765104/
5. Danoy, Patrick, Wei, Meng, Johanna, Hadler, Brown, Matthew A, Xu, Huji. 2011. Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. In Annals of the rheumatic diseases, 70, 1793-7. doi:10.1136/ard.2010.144576. https://pubmed.ncbi.nlm.nih.gov/21784728/
6. Ban, M, McCauley, J L, Zuvich, R, Compston, A, Sawcer, S. 2010. A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis. In Genes and immunity, 11, 660-4. doi:10.1038/gene.2010.36. https://pubmed.ncbi.nlm.nih.gov/20574445/
7. Yijia, Zheng, Li, Xiaoyu, Ma, Lina, Hao, Jianping, Wang, Jie. 2025. Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma. In Cancer immunology, immunotherapy : CII, 74, 131. doi:10.1007/s00262-025-03972-x. https://pubmed.ncbi.nlm.nih.gov/40029433/